PharmStars
Naomi Fried, founder and CEO of PharmStars, discusses the company's fifth cohort focused on solving challenges in therapeutic delivery and the 11 startups graduated from its accelerator program, including Cellular Vehicles and ZiO Health.
Drug development platform Quris raised another $9 million, and PharmStars is accepting applications for its accelerator cohort focused on women's health and health equity.
Also: Medicare Advantage insurer Zing Health partners with Papa. Verily and biopharma-company Sosei Heptares announce a research collaboration. Pharma-focused accelerator PharmStars’ next cohort will focus on neurological diseases.
The 10-week program was focused on clinical trial innovation.
HIMSS21
Naomi Fried, founder and CEO of PharmStars, discusses how her company mentors digital health startups and coaches pharma executives to prepare both parties for successful partnerships.
PharmStars will be launching its 10-week accelerator in the fall.